MX9606192A - Inhibidores de lactama biciclica de la enzima que convierte la interleucina-1-beta. - Google Patents

Inhibidores de lactama biciclica de la enzima que convierte la interleucina-1-beta.

Info

Publication number
MX9606192A
MX9606192A MX9606192A MX9606192A MX9606192A MX 9606192 A MX9606192 A MX 9606192A MX 9606192 A MX9606192 A MX 9606192A MX 9606192 A MX9606192 A MX 9606192A MX 9606192 A MX9606192 A MX 9606192A
Authority
MX
Mexico
Prior art keywords
interleukin
bicycling
converting enzyme
beta converting
lactam inhibitor
Prior art date
Application number
MX9606192A
Other languages
English (en)
Other versions
MXPA96006192A (es
Inventor
Roland E Dolle
Prasad V Chaturvedula
Tina Morgan-Ross
Stanley J Schmidt
Original Assignee
Sanofi Winthrop Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Winthrop Inc filed Critical Sanofi Winthrop Inc
Publication of MX9606192A publication Critical patent/MX9606192A/es
Publication of MXPA96006192A publication Critical patent/MXPA96006192A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06139—Dipeptides with the first amino acid being heterocyclic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • C07K5/0202—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -NH-X-X-C(=0)-, X being an optionally substituted carbon atom or a heteroatom, e.g. beta-amino acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • C07K5/021—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -NH-(X)n-C(=0)-, n being 5 or 6; for n > 6, classification in C07K5/06 - C07K5/10, according to the moiety having normal peptide bonds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06191—Dipeptides containing heteroatoms different from O, S, or N
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Transplantation (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

La presente invencion se refiere a los compuestos, composiciones y métodos para inhibir la actividad de la proteasa de interleucina-1 beta, que tiene la formula A, en donde Y = (a) o (b) o (c), Z = varias lactamas bicíclicas con un puente superior de nitrogeno.
MXPA/A/1996/006192A 1994-06-08 1995-06-07 Inhibidores de lactama biciclica de la enzima queconvierte la interleucina-1-beta MXPA96006192A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08255276 1994-06-08
US08/255,276 US5552400A (en) 1994-06-08 1994-06-08 Fused-bicyclic lactams as interleukin-1β converting enzyme inhibitors

Publications (2)

Publication Number Publication Date
MX9606192A true MX9606192A (es) 1998-06-30
MXPA96006192A MXPA96006192A (es) 1998-10-30

Family

ID=

Also Published As

Publication number Publication date
US5639745A (en) 1997-06-17
JPH10501244A (ja) 1998-02-03
EP0764167B1 (en) 2003-10-22
AU705882B2 (en) 1999-06-03
CA2192360A1 (en) 1995-12-14
DE69531990D1 (de) 2003-11-27
ES2341949T3 (es) 2010-06-30
JP4173536B2 (ja) 2008-10-29
CA2192360C (en) 2007-08-07
HU226979B1 (en) 2010-04-28
EP0764167A1 (en) 1997-03-26
PT764167E (pt) 2004-03-31
EP0764167A4 (en) 1997-09-17
HK1012630A1 (en) 1999-08-06
EP1391461B1 (en) 2010-04-14
AU2769995A (en) 1996-01-04
HU9603376D0 (en) 1997-01-28
DE69536064D1 (de) 2010-05-27
ATE464314T1 (de) 2010-04-15
ES2210294T3 (es) 2004-07-01
ATE252585T1 (de) 2003-11-15
HK1064102A1 (en) 2005-01-21
WO1995033751A1 (en) 1995-12-14
HUT76334A (en) 1997-08-28
US5552400A (en) 1996-09-03
DK0764167T3 (da) 2004-02-09
EP1391461A1 (en) 2004-02-25
DE69531990T2 (de) 2004-09-02

Similar Documents

Publication Publication Date Title
CA2192360A1 (en) Bicyclic lactam inhibitor of interleukin-1-beta converting enzyme
CY2093B1 (en) Dual action inhibitors
IL109901A (en) Peptidic phosphinyloxymethyl ketones and pharmaceutical compositions containing them
WO2000059497A8 (en) Pyrrolidine modulators of chemokine receptor activity
MY118498A (en) Lactam derivatives
PL331900A1 (en) 1,4-heterocyclic inhibitors of metaloprotease
HU9401679D0 (en) Alpha-heteroaryloxymethyl-ketones as interleukin-1-beta converting enzyme inhibitors
PH31249A (en) Inhibitors of hiv protease.
PL331838A1 (en) 1,3-diheterocyclic inhibitors of metaloproteases
CA2266015A1 (en) Tricyclic antitumor compounds being farnesyl protein transferase inhibitors
AU9298198A (en) Di-n-heterocyclic compounds, methods, and compositions for inhibiting parp activity
EP0567088A3 (en) Process for the preparation of an amylase inhibitor.
WO1996020210A3 (en) Diastereomerically pure 3-oxo and 3-thioxo-4-aza-androstan derivatives and the use thereof as antiandrogens
TW223630B (en) Retroviral protease inhibitors
ZA949148B (en) 5,6-dihydropyrone derivatives as protease inhibitors and antiviral agents
MX9605196A (es) Halometilamidas como inhibidores de la proteasa il-1b.
DE3273628D1 (en) Phosphonamidate compounds
HUP0004521A3 (en) Benzo(5,6)cycloheptapyridine cyclic ureas and lactams useful as farnesyl protein transferase inhibitors and medicaments containing the compounds
MX9500228A (es) N-oxidos de 4-arilpiperazinas y 4-arilpiperidinas.
EP0785786A4 (en) MICROBIAL SYNTHESIS OF HIV PROTEASE INHIBITORS
EP0785989A4 (en) MICROBIAL SYNTHESIS OF INHIBITORS OF THE HIV PROTEASE
ZA979867B (en) 1-(3-Aminoindazol-5-yl)-3-phenylmethyl-cyclic ureas useful as HIV protease inhibitors
ES2065843A1 (es) Aplicacion de ent-11 , 16-dihidroxi-18-nor-4a -carboximetil-oxido de manoilo como inhibidor de la adenilatociclasa.
MX9603347A (es) Derivados de disulfuro de 1,3,4,5-tetrahidro-benzo[c] azepin-3-ona de mercaptoacetilamido novedosos, utiles como inhibidores de encefalinasa y de enzima convertidora de angiotensina.
HU9500944D0 (en) N,n-substituted amino-methylen-imidazolinone derivatives as intermediates of 2-substituted 5-chloro-imidazol-4-carbaldeydes

Legal Events

Date Code Title Description
FG Grant or registration
HC Change of company name or juridical status

Owner name: PHARMACORE AB

PD Change of proprietorship

Owner name: VERTEX PHARMACEUTICALS INCORPORATED.*

MM Annulment or lapse due to non-payment of fees